Status:
UNKNOWN
The Correlation Between Genetic Polymorphism, Platelet Activity, Clopidogrel Responsiveness, and Serum Adipokine Concentration in Asian Acute Coronary Syndrome Patients
Lead Sponsor:
China Medical University Hospital
Conditions:
Acute Coronary Syndrome
Chronic Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
In this study, we evaluate the acute coronary syndrome patients to see if there is correlation between platelet activity, genetic polymorphism (CYP2C19 and ABCB1), serum adipokines level, and Clopidog...
Eligibility Criteria
Inclusion
- Age \> 18 y/o
- Acute coronary syndrome patients
- Chronic coronary artery disease patients
- Healthy volunteers
Exclusion
- Patient refusal
- Allergy to Clopidogrel
- Receive Gp IIb/IIIa inhibitor simultaneously
- Cancer history
- Severe renal and liver function impairment
- Coagulopathy
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01255267
Last Update
December 7 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan